Endoscopic sleeve gastrectomy <i>vs</i> traditional bariatric surgery: A paradigm shift in managing metabolic dysfunction-associated steatohepatitis and cirrhosis?

World J Gastrointest Pharmacol Ther · 2025 · PMC12686997 · PMID 41378077

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

While differences between medication classes did not reach statistical significance, GLP-1 RAs showed a trend toward greater efficacy at 18 and 24 months[ 95 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Endoscopic sleeve gastrectomy &lt;i&gt;vs&lt;/i&gt; traditional bariatric surgery: A paradigm shift in managing metabolic dysfunction-associated steatohepatitis and cirrhosis?

The sentences

Endoscopic sleeve gastrectomy <i>vs</i> traditional bariatric surgery: A paradigm shift in managing metabolic dysfunction-associated steatohepatitis and cirrhosis?